• Mashup Score: 0
    Key interventional cardiology takeaways from the SCAI 2022 conference - 2 year(s) ago

    Here are some key interventional cardiology takeaways from sessions presented at the Society for Cardiovascular Angiography and Interventions (SCAI) 2022 annual meeting in May. The society recently highlighted these points in a newsletter to its members. No-implant interatrial shunt for heart failure shows promising efficacy Early clinical…

    Source: Cardiovascular Business
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of CardioBusiness
      CardioBusiness

      Key interventional cardiology takeaways from the SCAI 2022 conference #Cardiotwitter #cardiology #Cathlab #Interventional #congenitalheart #Heartfailure #SCAI22 #SCAI2022 @SCAI https://t.co/MAxAyafemQ

  • Mashup Score: 9
    Dr. Sunil Rao, SCAI President—New Initiative - 2 year(s) ago

    Dr. Sunil Rao, SCAI President—New Initiative#SCAI2022

    Source: YouTube
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of SCAI
      SCAI

      SCAI President 2022-23, Sunil V. Rao, MD, FSCAI, speaks on three new initiatives that SCAI will undertake in the coming year to continue to shape the future of #InterventionalCardiology. Watch now: https://t.co/8GHgHElKDj @svraomd @scai_prez @chadialraies #SCAI2022 https://t.co/8UeqRKqw9C

  • Mashup Score: 3
    Conversations in Interventional Cardiology: NACMI Registry - 2 year(s) ago

    Join Drs. Odayme Quesada, Timothy Henry, Alexandra Lansky, and Mirvat Alasnag for a discussion on the accepted paper in JSCAI titled, “Sex Differences in Cli…

    Source: YouTube
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of SCAI
      SCAI

      ICYMI: #SCAI2022 #LateBreaking Sex Differences in Clinical Characteristics, Management Strategies, and Outcomes of #STEMI with COVID-19 #NACMI Registry, a conversation with @HenrytTimothy @AlexandraLansky @manalalasnag and @OdaymeMD https://t.co/bGRKDx1UfC https://t.co/PueQyAALMN

  • Mashup Score: 0
    SAFE PAD: Paclitaxel-coated devices noninferior to uncoated devices for mortality - 2 year(s) ago

    ATLANTA — An analysis of 160,000 Medicare beneficiaries demonstrated the noninferiority of paclitaxel-coated devices for mortality compared with uncoated devices for the treatment of peripheral artery disease, a speaker reported.In the analysis, presented at the Society for Cardiovascular Angiography and Interventions Scientific Sessions by Eric A. Secemsky, MD, MSc, RPVI, FACC, FSCAI,

    Source: www.healio.com
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of CardiologyToday
      CardiologyToday

      ICYMI: "We are yet to be able to replicate the harm associated with paclitaxel in any of the subsequent studies that have come out since the December 2018 meta-analysis.” @EricSecemskyMD @SCAI #SCAI2022 #Cardiotwitter https://t.co/qoRRiG6lL9

  • Mashup Score: 3
    SAFE PAD: Paclitaxel-coated devices noninferior to uncoated devices for mortality - 2 year(s) ago

    ATLANTA — An analysis of 160,000 Medicare beneficiaries demonstrated the noninferiority of paclitaxel-coated devices for mortality compared with uncoated devices for the treatment of peripheral artery disease, a speaker reported.In the analysis, presented at the Society for Cardiovascular Angiography and Interventions Scientific Sessions by Eric A. Secemsky, MD, MSc, RPVI, FACC, FSCAI,

    Source: www.healio.com
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of CardiologyToday
      CardiologyToday

      ICYMI: "We are yet to be able to replicate the harm associated with paclitaxel in any of the subsequent studies that have come out since the December 2018 meta-analysis.” @EricSecemskyMD @SCAI #SCAI2022 #Cardiotwitter https://t.co/qoRRiG6lL9

Load More